Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia. [electronic resource]
Producer: 19900817Description: 401-8 p. digitalISSN:- 0006-4971
- Antigens, CD -- analysis
- Antigens, Differentiation, T-Lymphocyte -- analysis
- CD3 Complex
- CD56 Antigen
- Cell Adhesion
- Cell Division
- Cytotoxicity, Immunologic
- Humans
- Interleukin-2 -- pharmacology
- Killer Cells, Lymphokine-Activated -- immunology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- immunology
- Philadelphia Chromosome
- Receptors, Antigen, T-Cell -- analysis
- Recombinant Proteins -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.